NanoViricides
NNVC
#10074
Rank
NZ$44.26 M
Marketcap
NZ$2.05
Share price
-4.00%
Change (1 day)
-24.26%
Change (1 year)

EPS for NanoViricides (NNVC)

EPS in 2025 (TTM): NZ-$1.03

According to NanoViricides's latest financial reports the company's current EPS (TTM) is NZ-$1.04. In 2024 the company made an earnings per share (EPS) of NZ-$1.20 an increase over its 2023 EPS that were of NZ-$1.27.

EPS history for NanoViricides from 2005 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$1.03-13.95%
2024NZ-$1.20-5.41%
2023NZ-$1.275.71%
2022NZ-$1.20-13.58%
2021NZ-$1.39-66.11%
2020NZ-$4.091.7%
2019NZ-$4.02-10.98%
2018NZ-$4.51-22.35%
2017NZ-$5.81-10.53%
2016NZ-$6.50375%
2015NZ-$1.37-85.19%
2014NZ-$9.2342.11%
2013NZ-$6.5026.67%
2012NZ-$5.13-6.25%
2011NZ-$5.4714.28%
2010NZ-$4.79100%
2009NZ-$2.39-0%
2008NZ-$2.39-33.33%
2007NZ-$3.59-0%
2006NZ-$3.594445.07%
2005NZ-$0.07901

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
BioCryst Pharmaceuticals
BCRX
NZ-$0.08551-91.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
NZ$3.63-447.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
NZ$11.15-1,168.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$5.08-586.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$12.99-1,344.88%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
NZ$6.15-689.50%๐Ÿ‡ฌ๐Ÿ‡ง UK